Company Quick10K Filing
China Jo-Jo Drugstores
10-Q 2019-12-31 Filed 2020-02-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-05-23 Public Filing
10-K 2019-03-31 Filed 2019-07-01
10-Q 2018-12-31 Filed 2019-02-14
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-29
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-06-29
10-Q 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-06-28
10-Q 2015-12-31 Filed 2016-02-12
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-12
10-K 2015-03-31 Filed 2015-06-29
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-12
10-K 2014-03-31 Filed 2014-06-27
10-Q 2013-12-31 Filed 2014-02-19
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-K 2013-03-31 Filed 2013-07-01
10-Q 2012-12-31 Filed 2013-02-14
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-K 2012-03-31 Filed 2012-07-02
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-K 2011-03-31 Filed 2011-06-29
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-06-29
10-Q 2009-12-31 Filed 2010-02-08
10-K 2009-07-31 Filed 2010-04-12
8-K 2020-06-15
8-K 2020-06-03
8-K 2020-06-01
8-K 2020-03-05
8-K 2020-02-14
8-K 2019-11-14
8-K 2019-08-14
8-K 2019-07-01
8-K 2019-04-22
8-K 2019-04-15
8-K 2019-04-11
8-K 2019-03-11
8-K 2019-03-04
8-K 2019-02-14
8-K 2018-11-14
8-K 2018-11-07
8-K 2018-10-26
8-K 2018-09-04
8-K 2018-08-14
8-K 2018-06-29
8-K 2018-03-30
8-K 2018-02-14

China Jo-Jo Drugstores Financials

CJJD Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Nexeo Solutions (NXEO) 757,054 11% 9.1 1% 2,179,100 1,359,600 4,040,400 451,900 19,100 169,200 1,533,454
Innophos Holdings (IPHS) 681,397 18% 20.0 2% 875,844 537,946 758,544 135,019 21,366 49,446 990,666
Hawkins (HWKN) 452,894 18% 9.4 7% 393,042 163,607 548,581 98,498 26,958 55,485 523,838
OMNOVA Solutions (OMN) 253,536 23% 10.7 1% 583,900 524,200 759,500 178,300 6,000 50,400 539,836
Foamix Pharmaceuticals (FOMX) 187,642 74% -2.8 -70% 81,583 28,054 1,168 860 -57,358 -57,278 159,797
MediWound (MDWD) 118,500 0% 35,276 0 0 0 0 118,411
Natural Alternatives International (NAII) 59,541 16% 4.0 4% 115,237 37,832 130,953 20,796 4,078 7,694 31,041
Mannatech (MTEX) 39,837 80% 1.4 2% 66,806 42,161 118,340 95,087 1,185 5,740 8,031
China Jo-Jo Drugstores (CJJD) 39,524 24% -45.8 -3% 87,150 65,526 111,004 26,449 -2,744 -481 22,025
Ocean Bio Chem (OBCI) 30,878 38% 8.3 7% 39,134 9,050 32,529 12,344 2,849 3,758 31,094
Cyanotech (CYAN) 18,636 41% 31.4 -3% 32,437 17,093 31,864 13,083 -1,090 788 24,748
CTI Industries (CTIB) 8,286 16% -2.5 -16% 32,897 30,950 33,481 5,342 -5,142 -3,674 9,028
Fuwei Films (FFHL) 6,793 14% 4.5 -2% 454,682 257,851 303,573 42,152 -8,960 -8,960 -40,115
Chromadex (CDXC) 249 55% 0.4 -54% 43,139 15,997 33,202 18,304 -23,294 -21,662 -8,507
Aurora Cannabis (ACB)
HEXO (HEXO)
Aphria (APHA)
Canopy Growth Corporation (CGC)
Cronos Group (CRON)
Happiness Biotech (HAPP) 0% 65,679 4,763 0 0 0 0 -14,801

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash4,5904,3403,8333,5083,7964,5242,7116,2973,1074,4453,3797,3531,7344,0241,6556,7104,3396,6726,0408,3524,64318,36414,36016,8388,39615,1338,9056,92220,60824,74523,15029,285
Accounts Receivable4,7067,37416,51726,98020,47312,97911,91212,69210,1926,7355,6776,7337,1129,2387,7348,5148,7518,0558,86210,0719,4418,5628,79410,20112,8408,3226,8787,83110,6378,6938,5907,244
Inventory7,5297,3626,8768,7707,6368,5879,12712,16818,2318,4197,2248,4229,77810,53911,77111,39410,26110,80310,73213,76710,5669,92310,48111,07713,50013,43013,70313,79910,48313,95510,80712,178
PP&E15,47015,30415,64720,97520,96920,76621,11121,31621,81321,52620,27220,38921,26923,11523,25722,34221,79522,00921,39921,35520,74321,00021,37021,24020,47217,25616,97615,96422,19123,18423,14022,460
Assets64,48766,30874,96188,24581,25167,83869,63770,26567,48845,90943,00749,47054,22959,50962,53863,71759,91962,07355,02261,18854,28167,17365,37470,16674,09673,81364,57764,70367,02572,73180,21887,150
Accounts Payable7,2755,51913,90623,83620,85513,78015,37519,45519,29614,55510,21814,01513,36715,91614,42718,15514,92016,66715,51021,20814,40219,44118,23023,09021,45225,26022,41922,51319,22423,10613,67523,606
Long-Term Debt7,91911,786
Liabilities16,41516,37322,61036,68333,01729,69031,49032,37437,68131,54528,86734,36138,54242,27545,02344,08740,91042,75735,53840,95533,80240,50939,32644,30848,98854,95046,35849,43753,32155,75956,72165,526
Stockholders' Equity49,93652,35151,56448,23638,14838,14737,89229,76914,32314,10115,07115,64817,19417,51519,62919,00919,31619,48420,23320,48026,66426,04825,85825,10818,86218,88715,90114,14218,16524,93323,171
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue22,22525,64425,05626,66515,59614,38715,33716,85517,83316,13016,45918,44421,32020,67221,31122,57824,70820,46920,93620,16120,61019,79221,67023,49126,81224,13922,77327,40930,91726,45325,28128,354
Cost of Revenue15,96718,81717,44723,24312,60611,30911,73513,90717,65417,13113,94915,67918,13816,69216,93618,60119,86116,15716,45415,80816,42616,18417,49317,93321,24119,32117,15621,61223,78119,89419,21921,660
Gross Profit6,2586,8277,6093,4222,9903,0783,6012,948179-1,0012,5112,7653,1823,9804,3763,9774,8474,3124,4824,3534,1843,6084,1785,5585,5724,8185,6175,7977,1366,5586,0616,693
R&D
SG&A4,0324,6755,9213,4136,4797,6764,3223,4719,0395,4742,8502,6802,806-2,0134,0174,2595,1551,6374,6014,4065,0223,0855,6427,2067,75910,6286,1827,43928,479-69,3978,8208,310
Tax8188268590-40-14040-362212314582-38351828171820271838-0573048-0296
Net Income1,6341,5771,691-1,528-3,487-9,854-788-546-8,735-15,287-347-361281,113111151-61880313198-835-5,038-1,419-1,169-1,626-12,846-697-1,603-2,2073,189-2,378-1,347
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1,9412,2892321,460-7303,309-3,2661,370-1,8453,646-3,0302,292-1,1732,672-2,4193,505-2,7653,220-2,2423,347-3,6113,091-8,9187,369-2,582-3394,720-8,1659,138
Cash Investing-709162-18-1,899-118-1,426-294-275-105-154-1,862-2,245-2141,288-78-566-36339-175-175-507-589-661-1,221-258-131-479-1,172-274
Cash Financing-1,497-2,98611,245-1,1461,638239476847434-7352,322-1,0031,30459-7621,388-278-1,08610,621-345-513687-600-3,250-887998,018-1,638